Cellectis Statistics

Total Valuation

Cellectis has a market cap or net worth of $106.38 million. The enterprise value is $72.33 million.

Market Cap	106.38M
Enterprise Value	72.33M

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025, after market close.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Cellectis has 72.29 million shares outstanding. The number of shares has increased by 57.25% in one year.

Current Share Class	n/a
Shares Outstanding	72.29M
Shares Change (YoY)	+57.25%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	38.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.94
Forward PS	2.93
PB Ratio	0.92
P/TBV Ratio	0.92
P/FCF Ratio	4.03
P/OCF Ratio	3.65
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.32
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	2.74

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.83.

Current Ratio	1.67
Quick Ratio	0.94
Debt / Equity	0.83
Debt / EBITDA	n/a
Debt / FCF	3.65
Interest Coverage	-7.09

Financial Efficiency

Return on equity (ROE) is -58.55% and return on invested capital (ROIC) is -16.23%.

Return on Equity (ROE)	-58.55%
Return on Assets (ROA)	-9.19%
Return on Invested Capital (ROIC)	-16.23%
Return on Capital Employed (ROCE)	-26.22%
Revenue Per Employee	$246,608
Profits Per Employee	-$272,667
Employee Count	222
Asset Turnover	0.15
Inventory Turnover	n/a

Taxes

In the past 12 months, Cellectis has paid $262,000 in taxes.

Income Tax	262,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.39% in the last 52 weeks. The beta is 3.20, so Cellectis's price volatility has been higher than the market average.

Beta (5Y)	3.20
52-Week Price Change	-21.39%
50-Day Moving Average	1.48
200-Day Moving Average	1.65
Relative Strength Index (RSI)	50.54
Average Volume (20 Days)	53,901

Short Selling Information

Short Interest	213,658
Short Previous Month	195,335
Short % of Shares Out	0.41%
Short % of Float	n/a
Short Ratio (days to cover)	4.13

Income Statement

In the last 12 months, Cellectis had revenue of $54.75 million and -$60.53 million in losses. Loss per share was -$0.62.

Revenue	54.75M
Gross Profit	54.75M
Operating Income	-52.84M
Pretax Income	-80.31M
Net Income	-60.53M
EBITDA	-41.05M
EBIT	-52.84M
Loss Per Share	-$0.62

Full Income Statement

Balance Sheet

The company has $127.64 million in cash and $96.23 million in debt, giving a net cash position of $31.41 million or $0.43 per share.

Cash & Cash Equivalents	127.64M
Total Debt	96.23M
Net Cash	31.41M
Net Cash Per Share	$0.43
Equity (Book Value)	116.20M
Book Value Per Share	1.61
Working Capital	109.26M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $29.14 million and capital expenditures -$2.76 million, giving a free cash flow of $26.38 million.

Operating Cash Flow	29.14M
Capital Expenditures	-2.76M
Free Cash Flow	26.38M
FCF Per Share	$0.36

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -96.52% and -110.57%.

Gross Margin	100.00%
Operating Margin	-96.52%
Pretax Margin	-110.09%
Profit Margin	-110.57%
EBITDA Margin	-74.98%
EBIT Margin	-96.52%
FCF Margin	48.19%

Dividends & Yields

Cellectis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-57.25%
Shareholder Yield	-57.25%
Earnings Yield	-56.90%
FCF Yield	24.80%

Analyst Forecast

The average price target for Cellectis is $4.00, which is 172.11% higher than the current price. The consensus rating is "Buy".

Price Target	$4.00
Price Target Difference	172.11%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	27.62%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cellectis has an Altman Z-Score of -0.95 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.95
Piotroski F-Score	5